Resistance to Photodynamic Therapy in Cancer (eBook)
XV, 248 Seiten
Springer International Publishing (Verlag)
978-3-319-12730-9 (ISBN)
Giulio Jori is Professor of Biophysics at the University of Padova, Italy. He has been a founding member and President of the European Society for Photobiology. His research interests are focused on basic mechanisms of photodynamic action at a cellular and tissue level, as well as investigations concerning the application of photodynamic therapy for the treatment of tumours and microbial infections. Dr. Jori is Editor-in-chief of Journal of Photochemistry and Photobiology and he was also chairman of the ownership board of the journal Photochemical and Photobiological Sciences. He has been the chief organizer of nine International Symposia on Photodynamic Therapy and Photodiagnosis in Clinical Practice. In addition, he has received an award for excellence in research from the European Society for Photobiology.
Valentina Rapozzi is a Researcher at the University of Udine, Italy. Dr. Rapozzi's research is focused on the antitumoral molecular pathways in photodynamic therapy. She is a member of the European Society for Photobiology, and a member of the Council of the Italian Society of Photobiology.
Giulio Jori is Professor of Biophysics at the University of Padova, Italy. He has been a founding member and President of the European Society for Photobiology. His research interests are focused on basic mechanisms of photodynamic action at a cellular and tissue level, as well as investigations concerning the application of photodynamic therapy for the treatment of tumours and microbial infections. Dr. Jori is Editor-in-chief of Journal of Photochemistry and Photobiology and he was also chairman of the ownership board of the journal Photochemical and Photobiological Sciences. He has been the chief organizer of nine International Symposia on Photodynamic Therapy and Photodiagnosis in Clinical Practice. In addition, he has received an award for excellence in research from the European Society for Photobiology. Valentina Rapozzi is a Researcher at the University of Udine, Italy. Dr. Rapozzi's research is focused on the antitumoral molecular pathways in photodynamic therapy. She is a member of the European Society for Photobiology, and a member of the Council of the Italian Society of Photobiology.
Introduction1. Basic and Clinical Aspects of photodynamic TherapyValentina Rapozzi and Giulio JoriMechanistic Aspects Involved in Resistance to PDT2. Mechanisms of Resistance to Photodynamic TherapyAdriana G. Casas, Christian Perotti, Gabriela Di Venosa and Alicira Batlle3. Tumor Vascular Microenvironment Determines responsiveness to Photodynamic TherapyShannon M. Gallagher-Colombo, Jarod C. Finlay and Theresa M. Busch4. Autophagy Pathways Activated in Response to PDT Contribute to Cell Resistance Against ROS DamageAbhishek D. Garg and Patrizia Agostinis5. Methods to isolate the Resistant Cells to Photodynamic TherapyAlicia Zamarròn, Sara E. Lucena, Nerea Salazar, Pedro Jaén, Salvador Gonzalez, Yolanda Gilaberte and Angeles JuarranzSpecific Strategies to Sensitize Tumor Cells to PDT6. GRP78-Targeting Subtilase Cytotoxin Sensitizes Cancer Cells to Photodynamic TherapyMalgorzata Firczuk, Magdalena Gabrysiak and Jakub Golab7. Optimization of Photodynamic Therapy Response by Survivin Gene Knockdown in Human Metastatic Breast CancerViviana A. Rivarola and Ingrid Sol Cogno8. Cellular Targets and Molecular Responses Associated with Photodynamic TherapyMarian Luna, Angela Ferrario, Natalie Rucker, Emma Balouzian, Sam Wong, Sophie Mansfield and Charles J. GomerApproaches to Reduce the Multi-Drug Resistance of Tumor Cells by PDT9. The Use of Nanoparticle-Delivered Photosensitizers Can Overcome the Development of Resistance to PDT in TumorsMagali Toussaint, Muriel Barberi-Heyob, Sophie Pinel and Celine Frochot 10. Mechanisms of tumor cells resistance to ALA/PDTZvi Malik, Abraham Nudelman and Benjamin Ehrenberg11. Overcoming the Resistance of Meolanoma to Photodynamic TherapySulbha K. Sharma, Ying-Ying Huang and Michael R.Hamblin
Erscheint lt. Verlag | 11.12.2014 |
---|---|
Reihe/Serie | Resistance to Targeted Anti-Cancer Therapeutics | Resistance to Targeted Anti-Cancer Therapeutics |
Zusatzinfo | XV, 248 p. 48 illus., 36 illus. in color. |
Verlagsort | Cham |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Studium |
Naturwissenschaften ► Biologie | |
Technik | |
Schlagworte | antibacterial drug resistance • Oxygen reactive species • PDT • Photosensitizers • phototherapy and cancer • Tumor cells |
ISBN-10 | 3-319-12730-6 / 3319127306 |
ISBN-13 | 978-3-319-12730-9 / 9783319127309 |
Haben Sie eine Frage zum Produkt? |
Größe: 7,2 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich